Ulcer Disease in the Excluded Segments after Roux-en-Y Gastric Bypass: a Current Review of the Literature

Standard

Ulcer Disease in the Excluded Segments after Roux-en-Y Gastric Bypass: a Current Review of the Literature. / Plitzko, Gabriel; Schmutz, Grégoire; Kröll, Dino; Nett, Philipp C; Borbély, Yves.

In: OBES SURG, Vol. 31, No. 3, 03.2021, p. 1280-1289.

Research output: SCORING: Contribution to journalSCORING: Review articleResearch

Harvard

APA

Vancouver

Bibtex

@article{ac8a0b48de3b42af87562be816f75a77,
title = "Ulcer Disease in the Excluded Segments after Roux-en-Y Gastric Bypass: a Current Review of the Literature",
abstract = "Ulcer disease in excluded segments after Roux-Y gastric bypass (RYGB) is rare but can evolve into a life-threatening situation. The excluded segments exhibit a different behavior from that of non-altered anatomy; perforated ulcers do not result in pneumoperitoneum or free fluid, and therefore must be met with a low threshold for surgical exploration. The anatomical changes after RYGB impede routine access to the remnant stomach and duodenum. There are various options to address bleeding or perforated ulcers. While oversewing and drainage preserves the anatomy and forgoes resection, remnant gastrectomy offers a definitive solution. The importance of traditional risk factors such as smoking or use of non-steroidal anti-inflammatory drugs is unclear. Eradication of Helicobacter pylori and secondary prophylaxis with proton-pump inhibitors is advisable, albeit in double-dose.",
keywords = "Gastrectomy, Gastric Bypass/adverse effects, Humans, Obesity, Morbid/surgery, Peptic Ulcer/etiology, Ulcer",
author = "Gabriel Plitzko and Gr{\'e}goire Schmutz and Dino Kr{\"o}ll and Nett, {Philipp C} and Yves Borb{\'e}ly",
year = "2021",
month = mar,
doi = "10.1007/s11695-020-05123-w",
language = "English",
volume = "31",
pages = "1280--1289",
journal = "OBES SURG",
issn = "0960-8923",
publisher = "Springer New York",
number = "3",

}

RIS

TY - JOUR

T1 - Ulcer Disease in the Excluded Segments after Roux-en-Y Gastric Bypass: a Current Review of the Literature

AU - Plitzko, Gabriel

AU - Schmutz, Grégoire

AU - Kröll, Dino

AU - Nett, Philipp C

AU - Borbély, Yves

PY - 2021/3

Y1 - 2021/3

N2 - Ulcer disease in excluded segments after Roux-Y gastric bypass (RYGB) is rare but can evolve into a life-threatening situation. The excluded segments exhibit a different behavior from that of non-altered anatomy; perforated ulcers do not result in pneumoperitoneum or free fluid, and therefore must be met with a low threshold for surgical exploration. The anatomical changes after RYGB impede routine access to the remnant stomach and duodenum. There are various options to address bleeding or perforated ulcers. While oversewing and drainage preserves the anatomy and forgoes resection, remnant gastrectomy offers a definitive solution. The importance of traditional risk factors such as smoking or use of non-steroidal anti-inflammatory drugs is unclear. Eradication of Helicobacter pylori and secondary prophylaxis with proton-pump inhibitors is advisable, albeit in double-dose.

AB - Ulcer disease in excluded segments after Roux-Y gastric bypass (RYGB) is rare but can evolve into a life-threatening situation. The excluded segments exhibit a different behavior from that of non-altered anatomy; perforated ulcers do not result in pneumoperitoneum or free fluid, and therefore must be met with a low threshold for surgical exploration. The anatomical changes after RYGB impede routine access to the remnant stomach and duodenum. There are various options to address bleeding or perforated ulcers. While oversewing and drainage preserves the anatomy and forgoes resection, remnant gastrectomy offers a definitive solution. The importance of traditional risk factors such as smoking or use of non-steroidal anti-inflammatory drugs is unclear. Eradication of Helicobacter pylori and secondary prophylaxis with proton-pump inhibitors is advisable, albeit in double-dose.

KW - Gastrectomy

KW - Gastric Bypass/adverse effects

KW - Humans

KW - Obesity, Morbid/surgery

KW - Peptic Ulcer/etiology

KW - Ulcer

U2 - 10.1007/s11695-020-05123-w

DO - 10.1007/s11695-020-05123-w

M3 - SCORING: Review article

C2 - 33230760

VL - 31

SP - 1280

EP - 1289

JO - OBES SURG

JF - OBES SURG

SN - 0960-8923

IS - 3

ER -